Navigation Links
Wright Therapy Products, Inc. Closes $3 million Financing Round
Date:12/7/2012

PITTSBURGH, Dec. 7, 2012 /PRNewswire/ -- Wright Therapy Products, Inc., a market leader in providing home-based solutions for patients suffering from lymphedema and venous insufficiency, announced today that they successfully closed a $3 million Series B financing round.  The capital raise was primarily subscribed by high-net-worth angel investors through Eagle Ventures, based in Shadyside, PA.

"We are very excited to complete the B round," said Michael Hinson, President and CEO of Wright Therapy.  "This funding will allow us to continue expanding our solution across the entire U.S.  Additionally, it will allow us to complete exciting new product development projects that we believe will lead to a significant competitive advantage in the marketplace by providing a unique treatment method for patients suffering from these life-altering diseases."

Jim Liken, Chairman of Wright's Board of Directors commented, "As a whole, our investors are very aware of the changing healthcare landscape and the need to provide cost-effective means to care for the patient.  I believe that is what attracted the B round investors to Wright Therapy.  Our ComplyCare™ solution is a disease management program focused on providing the most effective and compliant treatment for the patient which leads to the best clinical outcome."

About Wright Therapy Products, Inc.
Wright Therapy Products, Inc., based in Oakdale, Pennsylvania is a Joint Commission accredited medical device company that manufactures and sells pneumatic compression devices targeted for the home-based treatment of lymphedema and chronic venous insufficiency.  The devices have received 510(k) Clearance from the U.S. FDA to treat these diseases.  Our disease management program, ComplyCare™, is a comprehensive patient compliance program that helps to ensure the best clinical outcome for the patient while reducing the overall cost-of-care.  Our founder invented the world's first sequential gradient pump to treat a family member suffering from lymphedema and we continue to lead through innovation with a goal of providing the best treatment solution for patients afflicted with lymphedema or chronic venous insufficiency. 


'/>"/>
SOURCE Wright Therapy Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Omeros Responds to Misleading Announcement by Davis Wright Tremaine Concerning Settlement with Former Chief Financial Officer
2. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
3. Global Market for Radiation Therapy Equipment to Reach $6.8 Billion by 2018
4. Quebec Clinic Launches Canadian Use of Elektas Agility Beam-Shaping Innovation for Radiation Therapy of Cancer
5. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
6. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
7. Avaxia Biologics Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis
8. Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
9. Insulin Administration and Nutritional Therapy Requires Standardized Coordination, Says ECRI Institute PSO
10. Dynamic Healthcare Services Acquires HomeTown Oxygen, Pittsburgh, LLC, a Provider of Medical Equipment and Respiratory Therapy Products and Services based in Monroeville, PA
11. National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):